SCHEMBL13601626

SCHEMBL13601626

CCCOC(=O)CCC(=O)N1CCC(C)CC1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.57
ALDH1A1 P00352 8/20 0.49
LMNA P02545 4/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
HPGD P15428 3/20 0.49
TSHR P16473 4/20 0.49
POLB P06746 2/20 0.49
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 2/20 0.41
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601627 0.91 NPC1 (0.58) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601628 0.88 NPC1 (0.55) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601630 0.85 NPC1 (0.54) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601633 0.82 NPC1 (0.55) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601654 0.81 TSHR (0.51) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL10274470 0.79 NPC1 (0.74) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601455 0.79 POLB (0.51) ALDH1A1LMNAKMT2APOLBSMN1; SMN2
SCHEMBL27456239 0.79 NPC1 (0.59) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13601635 0.79 LMNA (0.55) NPC1ALDH1A1LMNAMEN1KMT2A
SCHEMBL14293823 0.78 GAA (0.50) NPC1ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed